GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jilin Aodong Pharmaceutical Group Co Ltd (SZSE:000623) » Definitions » EV-to-Revenue

Jilin Aodong Pharmaceutical Group Co (SZSE:000623) EV-to-Revenue : 4.72 (As of May. 15, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Jilin Aodong Pharmaceutical Group Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Jilin Aodong Pharmaceutical Group Co's enterprise value is ¥16,615 Mil. Jilin Aodong Pharmaceutical Group Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥3,523 Mil. Therefore, Jilin Aodong Pharmaceutical Group Co's EV-to-Revenue for today is 4.72.

The historical rank and industry rank for Jilin Aodong Pharmaceutical Group Co's EV-to-Revenue or its related term are showing as below:

SZSE:000623' s EV-to-Revenue Range Over the Past 10 Years
Min: 4.2   Med: 7.62   Max: 16.81
Current: 4.72

During the past 13 years, the highest EV-to-Revenue of Jilin Aodong Pharmaceutical Group Co was 16.81. The lowest was 4.20. And the median was 7.62.

SZSE:000623's EV-to-Revenue is ranked worse than
74.85% of 1026 companies
in the Drug Manufacturers industry
Industry Median: 2.375 vs SZSE:000623: 4.72

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-15), Jilin Aodong Pharmaceutical Group Co's stock price is ¥14.85. Jilin Aodong Pharmaceutical Group Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥3.03. Therefore, Jilin Aodong Pharmaceutical Group Co's PS Ratio for today is 4.91.


Jilin Aodong Pharmaceutical Group Co EV-to-Revenue Historical Data

The historical data trend for Jilin Aodong Pharmaceutical Group Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jilin Aodong Pharmaceutical Group Co EV-to-Revenue Chart

Jilin Aodong Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.96 8.02 8.83 6.15 5.11

Jilin Aodong Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.08 5.77 6.03 5.11 4.78

Competitive Comparison of Jilin Aodong Pharmaceutical Group Co's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Jilin Aodong Pharmaceutical Group Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jilin Aodong Pharmaceutical Group Co's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jilin Aodong Pharmaceutical Group Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Jilin Aodong Pharmaceutical Group Co's EV-to-Revenue falls into.



Jilin Aodong Pharmaceutical Group Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Jilin Aodong Pharmaceutical Group Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=16614.560/3522.796
=4.72

Jilin Aodong Pharmaceutical Group Co's current Enterprise Value is ¥16,615 Mil.
Jilin Aodong Pharmaceutical Group Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥3,523 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jilin Aodong Pharmaceutical Group Co  (SZSE:000623) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Jilin Aodong Pharmaceutical Group Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=14.85/3.027
=4.91

Jilin Aodong Pharmaceutical Group Co's share price for today is ¥14.85.
Jilin Aodong Pharmaceutical Group Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥3.03.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Jilin Aodong Pharmaceutical Group Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Jilin Aodong Pharmaceutical Group Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Jilin Aodong Pharmaceutical Group Co (SZSE:000623) Business Description

Traded in Other Exchanges
N/A
Address
No. 2158, Jidong Street, Dunhua, CHN, 133700
Jilin Aodong Pharmaceutical Group Co Ltd is engaged in manufacturing of pharmaceuticals. Its products include Anshen Bunao Liquid, Antelope Cough Syrup, Yangxue Yin Oral Liquid, Xinnao Shutong Capsule, Calf Spleen Extract Injection, Xuefu Zhuyu Oral Liquid, and others.

Jilin Aodong Pharmaceutical Group Co (SZSE:000623) Headlines

No Headlines